Cipla shares News

After this transaction, the promoter group will continue to hold 34.23 per cent in the company, it added. The promoter group does not plan to sell any further shares in the foreseeable future, the filing further said.

Chopra joined the company in 1996 and has served in various leadership positions across India. The other two executives are Nikhil Lalwani, head of India prescription business, and Kunal Khanna, cluster head of chronic and emerging business development and portfolio. The company, however, did not share the reasons for the exits.

Shares of pharma major Cipla on Friday fell by 3 percent after the company reported a consolidated net loss of Rs 61.79 crore for the March quarter.

Drug major Cipla on Friday reported an over two-fold jump in its consolidated net profit to Rs 650.61 crore for the quarter ended June 30, 2015 mainly on account of robust sales.

Shares of Cipla were trading at Rs 669.05 per scrip in the afternoon trade on BSE, up 2.86 percent from its previous close.

Cipla shares today ended at Rs 674.05 apiece on the BSE, down 0.05 percent from previous close.

The closing of the transaction is subject to receipt of applicable regulatory approvals in China, it added.

Shares in drugmaker Cipla gain after April-June operating margins beat some estimates.